Graphene Oxide/RhPTH(1-34)/Polylactide Composite Nanofibrous Scaffold for Bone Tissue Engineering

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Polymer Chemistry

Background:

• Polylactide (PLA) is a biocompatible and biodegradable polymer widely used in tissue repair.
• Enhancing PLA's mechanical properties and osteogenic potential is crucial for bone tissue engineering applications.
• Graphene oxide (GO) and parathyroid hormone (rhPTH(1-34)) are investigated for their synergistic effects in composite materials.

Purpose of the Study:

• To prepare and characterize polylactide/graphene oxide/parathyroid hormone (PLA/GO/rhPTH(1-34)) nanofiber membranes.
• To evaluate the mechanical properties, biocompatibility, and osteogenic differentiation of the developed composite membranes.
• To assess the potential of PLA/GO/rhPTH(1-34) composite membranes for bone tissue engineering.

Main Methods:

• Solution electrospinning technique used to fabricate PLA/GO/rhPTH(1-34) nanofiber membranes.
• Tensile strength testing to quantify mechanical properties.
• Biocompatibility and alkaline phosphatase (ALP) activity assays to evaluate osteogenic differentiation.

Main Results:

• The tensile strength of PLA/GO/rhPTH(1-34) membranes reached 2.64 MPa, a 110% increase compared to pure PLA (1.26 MPa).
• Graphene oxide addition did not significantly impact the biocompatibility of the PLA membranes.
• Alkaline phosphatase activity in PLA/GO/rhPTH(1-34) membranes was approximately 2.3 times higher than in pure PLA, indicating enhanced osteogenic differentiation.

Conclusions:

• PLA/GO/rhPTH(1-34) composite membranes exhibit significantly improved mechanical strength and osteogenic potential.
• The developed composite material shows promise as a candidate for bone tissue engineering applications.
• Further research is warranted to explore the full therapeutic potential of these advanced biomaterials.